Global private equity and venture capital news and research

Posts Tagged ‘Pharmedium’

30 January 2014

Baird Capital eyes 44x return from CD&R’s Pharmedium purchase

Pharmedium drugs Baird Capital reportedly stands to make a 44-times return on its investment in drug compounding business Pharmedium Healthcare through its sale to fellow buyout house Clayton Dubilier & Rice.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016